Abstract
Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues.
J Balzarini, S Velazquez, A San-Felix, A Karlsson, M J Perez-Perez, M J Camarasa and E De Clercq
Molecular Pharmacology January 1993, 43 (1) 109-114;